Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

41 views
October 9, 2024

Chapters

Decade of CLL Target Therapy & Recent Approvals

00:00

Treatment Sequencing Scenarios in CLL

01:38

Transition from Ibrutinib to Second-Gen BTK Inhibitors

03:54

Pirtobrutinib Approval & Resistance Challenges

05:51

CAR-T Liso-cel Approval & PFS Analysis

10:21

Emerging CLL Therapies & BTK Degraders

12:17

Comments 0
Login to view comments. Click here to Login